Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$122M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$89.5M |
| 3 |
Microsoft
MSFT
|
+$71.3M |
| 4 |
Visa
V
|
+$67M |
| 5 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$61.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$277M |
| 2 |
Micron Technology
MU
|
+$59M |
| 3 |
TCN
Tricon Residential Inc.
TCN
|
+$55.8M |
| 4 |
Zoetis
ZTS
|
+$48.4M |
| 5 |
Amgen
AMGN
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.69% |
| 2 | Industrials | 5.51% |
| 3 | Financials | 5.39% |
| 4 | Consumer Discretionary | 5.21% |
| 5 | Healthcare | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZIMV
1526
DELISTED
ZimVie
ZIMV
| $877K | ﹤0.01% |
+48,079
| New | +$788K |
|
1527
Sportradar
SRAD
$3.84B
| $877K | ﹤0.01% |
78,483
-88,624
| -53% | -$921K |
|
1528
Runway Growth Finance
RWAY
$275M
| $877K | ﹤0.01% |
74,581
+30,895
| +71% | +$375K |
|
1529
PC Connection
CNXN
$1.97B
| $874K | ﹤0.01% |
13,618
+8,930
| +190% | +$579K |
|
1530
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.3B
| $874K | ﹤0.01% |
9,578
-81,812
| -90% | -$7.27M |
|
1531
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.84B
| $873K | ﹤0.01% |
+11,502
| New | +$873K |
|
1532
Teekay Tankers
TNK
$3.12B
| $872K | ﹤0.01% |
12,676
-18,754
| -60% | -$1.22M |
|
1533
HUB Group
HUBG
$2.39B
| $872K | ﹤0.01% |
20,256
-59,321
| -75% | -$2.51M |
|
1534
Universal Corp
UVV
$1.14B
| $867K | ﹤0.01% |
17,982
-11,823
| -40% | -$590K |
|
1535
PUT
Sherwin-Williams
SHW
$84.6B
| $865K | ﹤0.01% |
2,900
+1,200
| +71% | +$371K |
|
1536
Ichor Holdings
ICHR
$2.15B
| $864K | ﹤0.01% |
+22,411
| New | +$854K |
|
1537
The RealReal
REAL
$1.34B
| $862K | ﹤0.01% |
270,244
-28,334
| -9% | -$105K |
|
|
SNCY
1538
DELISTED
Sun Country Airlines
SNCY
| $861K | ﹤0.01% |
+68,526
| New | +$844K |
|
1539
Pulmonx
LUNG
$105M
| $860K | ﹤0.01% |
135,685
+16,215
| +14% | +$125K |
|
1540
W.P. Carey
WPC
$16.3B
| $859K | ﹤0.01% |
+15,613
| New | +$880K |
|
1541
PUT
PayPal
PYPL
$53.2B
| $859K | ﹤0.01% |
14,800
-47,300
| -76% | -$3.01M |
|
1542
CALL
Planet Fitness
PLNT
$3.91B
| $854K | ﹤0.01% |
11,600
+5,200
| +81% | +$337K |
|
1543
ATN International
ATNI
$475M
| $853K | ﹤0.01% |
+37,410
| New | +$911K |
|
|
MORF
1544
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $852K | ﹤0.01% |
25,002
-882
| -3% | -$26.1K |
|
1545
CALL
Air Products & Chemicals
APD
$67.7B
| $852K | ﹤0.01% |
3,300
-18,000
| -85% | -$4.57M |
|
1546
Lindsay Corp
LNN
$1.16B
| $850K | ﹤0.01% |
+6,919
| New | +$805K |
|
1547
AngioDynamics
ANGO
$654M
| $843K | ﹤0.01% |
139,366
+38,163
| +38% | +$235K |
|
1548
Veracyte
VCYT
$3.49B
| $843K | ﹤0.01% |
+38,884
| New | +$818K |
|
1549
Insperity
NSP
$1.98B
| $837K | ﹤0.01% |
+9,180
| New | +$930K |
|
|
ALX
1550
Alexander's
ALX
$1.37B
| $836K | ﹤0.01% |
3,716
-273
| -7% | -$58.8K |
|
Similar funds
Paul Tudor Jones's Q2 2024 Portfolio in Review
As of Q2 2024, Paul Tudor Jones held 2,929 positions worth $19.5B, up 24% from $15.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Paul Tudor Jones deployed $4.18B of net new capital in Q2 2024, opening 786 new positions and adding to 755 existing holdings. Its largest new stake was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 8.9% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $59M trimmed.
- Paul Tudor Jones's largest Q2 2024 buy was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
- Paul Tudor Jones added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $122M increase.
- Paul Tudor Jones's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $59M.
- Paul Tudor Jones fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $277M.
- Paul Tudor Jones's ten largest holdings make up 34% of its $19.5B portfolio in Q2 2024.
- Paul Tudor Jones opened 786 new positions and closed 671 in Q2 2024.
- Paul Tudor Jones's portfolio value rose 24% quarter-over-quarter to $19.5B.
Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.